Live Breaking News & Updates on Ulrich Keller

Stay updated with breaking news from Ulrich keller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PET Imaging Tracer Effective for Diagnosing and Managing Rare CNS B-cell Lymphoma


PET Imaging Tracer Effective for Diagnosing and Managing Rare CNS B-cell Lymphoma
CXCR4-directed PET correlates with MRI-determined lymphoma lesions. Depicted are representative MR images (T1c- and FLAIR- sequences), and the corresponding CXCR4- directed PET images and fusion images (MRI-FLAIR and PET), of two patients with PCNSL and SCNSL, respectively. Images created by Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.
December 14, 2020   Positron emission tomography (PET) imaging with 68Ga-pentixafor is an effective diagnostic tool for central nervous system (CNS) B-cell lymphoma, according to a proof-of-concept study published in the December issue of The  ....

Peter Herhaus , Benjamin Franklin , Ulrich Keller , Journal Of Nuclear Medicine , School Of Medicine At Technische Universit , Campus Benjamin Franklin , Technische Universit , பெஞ்சமின் பிராங்க்ளின் , உல்ரிச் கெல்லரர் , இதழ் ஆஃப் அணு மருந்து , வளாகம் பெஞ்சமின் பிராங்க்ளின் ,

68Ga-pentixafor PET imaging is an effective diagnostic tool for CNS B-cell lymphoma


68Ga-pentixafor PET imaging is an effective diagnostic tool for CNS B-cell lymphoma
Positron emission tomography (PET) imaging with
68Ga-pentixafor is an effective diagnostic tool for central nervous system (CNS) B-cell lymphoma, according to a proof-of-concept study published in the December issue of The
Journal of Nuclear Medicine. Targeting the CXCR4 biomarker involved in the growth, survival and dissemination of aggressive B-cell lymphoma,
68Ga-pentixafor PET imaging shows excellent contrast characteristics between lymphoma lesions and surrounding healthy brain tissue and may be suitable for risk stratification and response assessment.
CNS B-cell lymphoma is a rare malignancy that has several clinical challenges, including diagnosis, risk stratification and optimization of treatment. Magnetic resonance imaging (MRI) is the current standard imaging technology for this disease, and while it provides high sensitivity, it offers only moderate specificity. No ....

Peter Herhaus , Benjamin Franklin , Ulrich Keller , Emily Henderson , Journal Of Nuclear Medicine , School Of Medicine At Technische Universit , Campus Benjamin Franklin , Technische Universit , பெஞ்சமின் பிராங்க்ளின் , உல்ரிச் கெல்லரர் , எமிலி ஹென்டர்சன் , இதழ் ஆஃப் அணு மருந்து , வளாகம் பெஞ்சமின் பிராங்க்ளின் ,